A systemic vaccine based on Escherichia coli O157:H7 bacterial ghosts [BGs] reduces the excretion of E. coli O157:H7 in calves
Cattle are the main reservoir of enterohemorrhagic . Escherichia coli O157:H7, a bacterium that, in humans, causes hemorrhagic colitis and hemolytic uremic syndrome [HUS], a life-threatening disease, especially in children and older people. Therefore, the development of vaccines preventing colonizat...
Guardado en:
| Otros Autores: | , , , , , , , , , , , , |
|---|---|
| Formato: | Artículo |
| Lenguaje: | Inglés |
| Materias: | |
| Acceso en línea: | http://ri.agro.uba.ar/files/intranet/articulo/2012Vilte.pdf LINK AL EDITOR |
| Aporte de: | Registro referencial: Solicitar el recurso aquí |
| Sumario: | Cattle are the main reservoir of enterohemorrhagic . Escherichia coli O157:H7, a bacterium that, in humans, causes hemorrhagic colitis and hemolytic uremic syndrome [HUS], a life-threatening disease, especially in children and older people. Therefore, the development of vaccines preventing colonization of cattle by . E. coli O157:H7 could be a main tool for an HUS control program. In the present study, we evaluated bacterial ghosts [BGs] of . E. coli O157:H7 as an experimental vaccine against this pathogen. BGs are empty envelopes of Gram-negative bacteria, which retain the morphological surface make-up of their living counterparts and are produced by controlled expression of the cloned protein E, which causes loss of all the cytoplasm content. In this work, . E. coli O157:H7 BGs were used for subcutaneous immunization of calves. The vaccinated animals elicited significant levels of BG-specific IgG but not IgA antibodies in serum. Low levels of IgA and IgG antibodies against BGs were detected in saliva from vaccinated animals. Following oral challenge with . E. coli O157:H7, a significant reduction in both the duration and total bacterial shedding was observed in vaccinated calves compared to the nonimmunized group. We demonstrated that systemic vaccination with . E. coli O157 BGs provides protection in a bovine experimental model. Further research is needed to reach a higher mucosal immune response leading to an optimal vaccine. |
|---|---|
| ISSN: | 0165-2427 |